natgillin/translations-raw huggingface dataset:
The active ingredient of Bretaris Genuair is aclidinium bromide, which belongs to a group of medicines called bronchodilators.
Bretaris Genuairi toimeaine on aklidiinbromiid, mis kuulub bronhodilaatorite hulka.
The active ingredient of Caelyx is doxorubicin hydrochloride, a cytotoxic anthracycline antibiotic obtained from Streptomyces peucetius var. caesius.
Caelyx’i toimeaineks on doksorubitsiinvesinikkloriid, Streptomyces peucetius var. caesius’est saadav tsütotoksiline antratsükliinide gruppi kuuluv antibiootikum.
The active ingredient of Eklira Genuair is aclidinium bromide, which belongs to a group of medicines called bronchodilators.
Eklira Genuairi toimeaine on aklidiinbromiid, mis kuulub bronhodilaatorite hulka.
The active ingredient of Imlygic is talimogene laherparepvec.
Imlygic’u toimeaine on talimogeenlaherparepvek.
The active ingredient of ProZinc, insulin human (rDNA), is produced by a method known as ‘recombinant DNA technology’: it is made by yeast cells into which a gene (segment of DNA) has been introduced that makes the yeast cells able to produce insulin.
ProZinci toimeainet iniminsuliini valmistatakse rekombinant-tehnika abil: insuliini toodab pärm, millele on lisatud insuliini teket võimaldav geen (DNA).
The active ingredient sucroferric oxyhydroxide contains 750 mg sucrose and 700 mg starches.
Toimeaine sahharo-raud(III)oksohüdroksiid sisaldab 750 mg sahharoosi ja 700 mg tärklisi.
The active ingredient vortioxetine (D,L)-lactate is classified as a PBT-substance (persistent, bioaccumulative and toxic; risk to fish).
Toimeainet vortioksetiin-(D,L)-laktaati on klassifitseeritud kui PBT (püsiv, bioakumuleeruv ja toksiline aine; ohtlik kaladele).
The active ingredient vortioxetine hydrobromide is classified as a PBT-substance (persistent, bioaccumulative and toxic; risk to fish).
Toimeainet vortioksetiinvesinikbromiid on klassifitseeritud kui PBT (püsiv, bioakumuleeruv ja toksiline aine; ohtlik kaladele).
The active ingredients are as follows:
Ravimi toimeained on järgmised:
The active ingredients are as follows:
Toimeained on:
The active ingredients are irbesartan and hydrochlorothiazide.
Toimeained on irbesartaan ja hüdroklorotiasiid.
The active ingredients of Combivir may inhibit cellular DNA replication and zidovudine has been shown to be transplacental carcinogen in one animal study (see section 5.3).
Combivir’i toimeained võivad pärssida tsellulaarset DNA replikatsiooni ning ühes loomkatses on näidatud, et zidovudiin on transplatsentaarne kartsinogeen (vt lõik 5.3).
The active ingredients of Trizivir may inhibit cellular DNA replication, zidovudine has been shown to be transplacental carcinogen in one animal study and abacavir has been shown to be carcinogenic in animal models (see section 5.3).
Trizivir’i toimeained võivad pärssida tsellulaarset DNA replikatsiooni, ühes loomkatses on näidatud, et zidovudiin on transplatsentaarne kartsinogeen ning loomkatsetes on abakaviir olnud kartsinogeenne (vt lõik 5.3).
The active metabolite 3-AT has a mean concentration of 57.9 ng/g and 441 ng/g, respectively.
Aktiivse metaboliidi 3-AT vastavad keskmised kontsentratsioonid on 57,9 ng/g ja 441 ng/g.
The active metabolite has a half-life of 6.2–13.5 h.
Aktiivse metaboliidi poolväärtusaeg on 6,2…13,5 tundi.
The active metabolite is a weak substrate of the breast cancer resistance protein (BCRP).
Aktiivne metaboliit on nõrk rinnavähi resistentsuse valgu (breast cancer resistance protein, BCRP) substraat.
The active metabolite was not detected in any of the 162 patients at any time point.
Aktiivset metaboliiti ei tuvastatud ühelgi ajaperioodil ühelgi 162-st patsiendist.
The active metabolite, N-desethyloxybutynin, has pharmacological activity on the human detrusor muscle that is similar to that of oxybutynin in vitro studies, but has a greater binding affinity for parotid tissue than oxybutynin.
Aktiivse metaboliidi N-desetüüloksübutüniini farmakoloogiline aktiivsus inimese detruusorlihasele sarnaneb oksübutüniini aktiivsusele in vitro uuringutes, kuid selle seondumisafiinsus kõrvasüljenäärme koega on suurem kui oksübutüniinil.
The active metabolite’s exposure (AUC) has moderate to low between-subject (27%) and within-subject (19%) variability.
Aktiivse metaboliidi ekspositsioonil (AUC) on mõõdukas kuni madal inter- (27 %) ja individuaalne (19 %) varieeruvus.
The active metabolite’s exposure (AUC) increases proportionally over the therapeutic dose range.
Aktiivse metaboliidi ekspositsioon (AUC) suureneb proportsionaalselt terapeutilise annuse ulatuses.
The active substance (in the powder in the vial) is concentrate of proteolytic enzymes enriched in bromelain: 2 g, corresponding to 0.09 g/g concentrate of proteolytic enzymes enriched in bromelain after mixing.
Toimeaine (viaalis sisalduv pulber) on bromelaiinis rikastatud proteolüütiliste ensüümide kontsentraat: 2 g, mis pärast kokku segamist vastab 0,09 g/g bromelaiinis rikastatud proteolüütiliste ensüümide kontsentraadile.
The active substance (in the powder in the vial) is concentrate of proteolytic enzymes enriched in bromelain: 5 g, corresponding to 0.09 g/g concentrate of proteolytic enzymes enriched in bromelain after mixing.
Toimeaine (viaalis sisalduv pulber) on bromelaiinis rikastatud proteolüütiliste ensüümide kontsentraat: 5 g, mis pärast kokku segamist vastab 0,09 g/g bromelaiinis rikastatud proteolüütiliste ensüümide kontsentraadile.
The active substance accelerated re-epithelialization in an in vitro wound scratch assay using human primary keratinocytes at the dosage of 1 μg/ml, and in a porcine ex vivo wound healing model at the dosage of 10 µg/ml.
Toimeaine kiirendas reepiteliseerumist in vitro kriimustushaava testis, kus kasutati inimese esmaseid keratinotsüüte annuses 1 μg/ml ja sigade ex vivo haava paranemise mudelis annuses 10 µg/ml.
The active substance being a principle of biological origin intended to produce active immunity is not within the scope of Regulation (EC) 470/2009.
Bioloogilise päritoluga aktiivne toimeaine, mille ülesandeks on tekitada aktiivset immuunsust, ei loeta määruse (EÜ) number 470/2009 rakendusalasse kuuluvaks.
The active substance being a principle of biological origin intended to produce active immunity is not within the scope of Regulation (EC) No 470/2009.
Aktiivse immuunsuse tekitamiseks mõeldud bioloogilist päritolu põhikomponendina ei kuulu toimeaine määruse nr.
The active substance being a principle of biological origin intended to produce active immunity is not within the scope of Regulation (EC) No 470/2009.
Toimeaine, mis on bioloogilise päritoluga põhikomponent ja mõeldud aktiivse immuunsuse ei kuulu Määruse (EÜ) nr 470/2009 reguleerimisalasse.
The active substance being a principle of biological origin intended to produce active immunity is not within the scope of Regulation (EC) No 470/2009.
Toimeaine, mis põhimõtteliselt on bioloogilist päritolu ja mõeldud aktiivse immuunsuse esile kutsumiseks ei kuulu Määruse (EL) nr 470/2009 reguleerimisalasse.
The active substance consists of 300,000 - 1,200,000 of your living eye cells, on average 3.5% of which are stem cells.
Toimeaine on teie silma 300 000 – 1 200 000 elusrakku, millest keskmiselt 3,5% on tüvirakud.
The active substance edoxaban tosilate is persistent in the environment (for instructions on disposal see section 6.6).
Toimeaine edoksabaantosilaat on keskkonnas püsiv (juhiseid hävitamise kohta vt lõik 6.6).
The active substance imatinib demonstrates an environmental risk for sediment organisms.
Toimeaine imatiniib kujutab keskkonnaohtu setteorganismidele
The active substance in 1 dose (0.5 ml) of Fendrix is:
Toimeaine sisaldus Fendrixi 1 annuses (0,5 ml):
The active substance in Abasaglar, insulin glargine, is produced by a method known as ‘recombinant DNA technology’: it is made by bacteria into which a gene (DNA) has been introduced that makes them able to produce insulin glargine.
Abasaglar toimeainet glargiininsuliini valmistatakse rekombinant-DNA-tehnika abil: seda toodavad bakterid, millele on lisatud insuliini teket võimaldav geen (DNA)
The active substance in Ablavar, gadofosveset trisodium, contains gadolinium, a ‘rare-earth’ metal element.
Ablavari toimeaine trinaatriumgadofosveset sisaldab gadoliiniumi, mis on haruldaste muldmetallide hulka kuuluv keemiline element.
The active substance in Abraxane, paclitaxel, belongs to the group of cancer medicines known as the ‘taxanes’.
Abraxane toimeaine paklitakseel kuulub vähiravimite taksaanide rühma.
The active substance in Abseamed, epoetin alfa, is a copy of a hormone called erythropoietin, and works in exactly the same way as the natural hormone to stimulate the production of red blood cells from the bone marrow.
Abseamedi toimeaine alfaepoetiin on hormooni erütropoetiini koopia ja toimib täpselt samamoodi kui looduslik hormoon, stimuleerides luuüdis punaliblede teket.
The active substance in Actos is pioglitazone.
Actose toimeaine on pioglitasoon.
The active substance in Actraphane, human insulin, is produced by a method known as ‘recombinant technology’: the insulin is made by yeast cells into which a gene (DNA) has been introduced, which makes them able to produce insulin.
Actraphane toimeainet iniminsuliini valmistatakse rekombinant-DNA-tehnika abil: insuliini toodab pärm, millele on lisatud insuliini teket võimaldav geen (DNA).
The active substance in Actrapid, human insulin, is produced by a method known as ‘recombinant technology’: the insulin is made by a yeast that has received a gene (DNA), which makes it able to produce insulin.
Actrapidi toimeainet iniminsuliini valmistatakse rekombinant-tehnika abil: insuliini toodab pärm, millele on lisatud insuliini teket võimaldav geen (DNA).
The active substance in Adcetris, brentuximab vedotin, is made up of a CD30 monoclonal antibody (a type of protein that attaches to CD30).
Adcetrise toimeaine brentuksimaabvedotiin sisaldab CD30 monoklonaalset antikeha (teatud valk, mis seondub CD30 rakkudega).
The active substance in Adcirca, tadalafil, belongs to a group of medicines called ‘phosphodiesterase type 5 (PDE5) inhibitors’, which means that it blocks the PDE5 enzyme.
Adcirca toimeaine tadalafiil kuulub fosfodiesteraas-5 (PDE5) inhibiitorite ravimirühma, st tadalafiil blokeerib ensüümi PDE5.
The active substance in Adempas, riociguat, stimulates an enzyme called ‘soluble guanylate cyclase’ in the blood vessels of the lungs, which causes the blood vessels to relax and widen.
Adempase toimeaine riotsiguaat stimuleerib kopsuveresoontes ensüümi lahustuvat guanülaattsüklaasi, mis lõõgastab ja laiendab veresooni.
The active substance in Advate, octocog alfa, is a substance that helps the blood to clot.
Advate toimeaine alfaoktokog on vere hüübimistegurina toimiv valk.
The active substance in Afinitor, everolimus, is a cancer medicine, which acts by blocking a protein called ‘mammalian target of rapamycin’ (mTOR).
Afinitori toimeaine everoliimus on vähiravim, mille toime seisneb valgu mTOR (imetajate rapamütsiinisihtvalk) blokeerimises.
The active substance in Alimta, pemetrexed, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells), which belongs to the group ‘antimetabolites’.
Alimta toimeaine pemetrekseed on antimetaboliitide rühma kuuluv tsütotoksiline ravim (ravim, mis hävitab poolduvaid rakke, näiteks vähirakke).
The active substance in Aloxi, palonosetron, is a ‘5HT3 antagonist’.
Aloxi toimeaine palonosetroon on 5HT3 antagonist.
The active substance in Altargo, retapamulin, is an antibiotic belonging to the ‘pleuromutilin’ class.
Altargos toimeainena sisalduv retapamuliin on pleuromutiliinide rühma kuuluv antibiootikum.
The active substance in Amyvid, florbetapir (18F), is a radiopharmaceutical that emits low amounts of radiation and works by targeting and attaching to β-amyloid plaques in the brain.
Amyvidi toimeaine florbetapiir (18F) on radiofarmatseutiline ravim, mis kiirgab väikeses koguses radioaktiivsust.
The active substance in Angiox, bivalirudin, is a synthetic substance originally derived from hirudin, the anticoagulant substance produced by leeches.
Angioxi toimeaine bivalirudiin on sünteetiline aine, mida saadakse hirudiinist – kaanide eritatavast hüübimisvastasest ainest.
The active substance in Apidra, insulin glulisine, is produced by a method known as ‘recombinant DNA technology’: it is made by a bacterium that has received a gene (DNA), which makes it able to produce insulin glulisine.
Apidra toimeainet glulisiininsuliini valmistatakse rekombinant-DNA-tehnika abil: glulisiininsuliini toodab bakter, millele on lisatud glulisiininsuliini teket võimaldav geen (DNA).
The active substance in Aprovel, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Aproveli toimeaine irbesartaan on angiotensiin II retseptori antagonist, mis blokeerib organismi hormooni angiotensiin II toime.
The active substance in Armisarte, pemetrexed, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells), which belongs to the group ‘antimetabolites’.
Armisarte toimeaine pemetrekseed on antimetaboliitide rühma kuuluv tsütotoksiline ravim (ravim, mis hävitab poolduvaid rakke, näiteks vähirakke).
The active substance in Atriance, nelabarine, is a cytotoxic, a medicine that kills cells that are dividing, such as cancer cells.
Atriance toimeaine nelarabiin on tsütotoksiline aine, mis hävitab poolduvaid rakke, näiteks vähirakke.
The active substance in ATryn, antithrombin alfa, is a copy of the natural blood protein antithrombin, which is produced by ‘recombinant DNA technology’: it is extracted from the milk of goats that have had a gene (DNA) inserted, which makes them able to produce the human protein in their milk.
ATryni toimeaine alfa-antitrombiin on loodusliku verevalgu antitrombiini analoog, mida valmistatakse rekombinant-DNA-tehnika abil: seda eraldatakse selliste kitsede piimast, kelle rakkudesse on lisatud geen (DNA), mis võimaldab tekitada nende piimas inimvalku.
The active substance in Aubagio, teriflunomide, blocks an enzyme called ‘dihydro-orotate dehydrogenase’ which is necessary for cells to multiply.
Aubagio toimeaine teriflunomiid blokeerib ensüümi dihüdroorotaat-dehüdrogenaasi, mida on vaja rakkude paljunemiseks.
The active substance in Avandia, rosiglitazone, makes cells (fat, muscle and liver) more sensitive to insulin, which means that the body makes better use of the insulin it produces.
Avandia toimeaine rosiglitasoon suurendab rakkude (rasva-, lihas- ja maksarakud) tundlikkust insuliini suhtes, mis tähendab, et organism kasutab enda toodetavat insuliini paremini ära.
The active substance in Avonex, interferon beta-1a, belongs to the group ‘interferons’.
Avonexi toimeaine beeta-1a-interferoon kuulub interferoonide rühma.
The active substance in Azilect, rasagiline, is a ‘monoamine oxidase-B inhibitor’.
Azilecti toimeaine rasagiliin on monoamiini oksüdaasi-B inhibiitor.
The active substance in Benepali is etanercept.
Benepali toimeaine on etanertsept.
The active substance in Beromun, tasonermin, is produced by a method known as ‘recombinant DNA technology’: it is made by bacteria that have received a gene (DNA), which makes them able to produce TNFα.
Beromuni toimeainet tasonermiini toodetakse rekombinant-DNA-tehnika abil: tasonermiini toodavad bakterid, millesse on lisatud TNFα teket võimaldav geen (DNA).
The active substance in Betaferon, interferon beta-1b, belongs to a group of medicines known as interferons.
Betaferoni toimeaine beeta-1b-interferoon kuulub interferoonide rühma.
The active substance in Binocrit, epoetin alfa, is a copy of a hormone called erythropoietin, and works in exactly the same way as the natural hormone to stimulate the production of red blood cells from the bone marrow.
Binocriti toimeaine alfaepoetiin on hormooni erütropoetiini koopia ja toimib täpselt samamoodi kui looduslik hormoon, stimuleerides luuüdis erütrotsüütide teket.
The active substance in Blincyto, blinatumomab, is a type of antibody that has been designed to recognise and attach to two proteins:
Blincyto toimeaine blinatumomab on antikeha, mis tunneb ära ja seondub kahe valguga:
The active substance in Bortezomib Accord, bortezomib, is a proteasome inhibitor.
Bortezomib Accordi toimeaine bortesomiib on proteasoomiinhibiitor.
The active substance in Bosulif, bosutinib, is a tyrosine kinase inhibitor.
Bosulifi toimeaine bosutiniib on türosiinkinaasiinhibiitor.
The active substance in Bravecto, fluralaner, acts as an ‘ectoparasiticide’.
Bravectos toimeainena sisalduv fluralaneer toimib ektoparasititsiidina.
The active substance in Bretaris Genuair, aclidinium bromide, is an anticholinergic bronchodilator.
Bretaris Genuairi toimeaine aklidiiniumbromiid on antikolinergiline bronhodilataator.
The active substance in Bridion, sugammadex, is a ‘selective relaxant binding agent’.
Bridioni toimeaine sugammadeks on selektiivne relaksante siduv aine.
The active substance in Brinavess, vernakalant, is an anti-arrhythmic medicine.
Brinavessi toimeaine vernakalant on arütmia (südame rütmihäirete) ravim.
The active substance in Briviact, brivaracetam, is an epilepsy medicine.
Briviacti toimeaine brivaratsetaam on epilepsiaravim.
The active substance in Busilvex, busulfan, belongs to a group of medicines called ‘alkylating agents’.
Busilvexi toimeaine busulfaan kuulub alküülivate ainete ravimirühma.
The active substance in Busulfan Fresenius Kabi, busulfan, belongs to a group of medicines called ‘alkylating agents’.
Busulfan Fresenius Kabi toimeaine busulfaan kuulub alküülivate ainete ravimirühma.
The active substance in Caelyx, doxorubicin hydrochloride, is a cytotoxic medicine that belongs to the group ‘anthracyclines’.
Caelyxi toimeaine doksorubitsiinvesinikkloriid on antratsükliinide rühma kuuluv tsütotoksiline ravim.
The active substance in Cancidas, caspofungin, belongs to a group of antifungal medicines known as ‘echinocandins’.
Cancidase toimeaine kaspofungiin kuulub seeneravimite ehhinokandiinide rühma.
The active substance in Capecitabine Accord, capecitabine, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells) that belongs to the group ‘anti-metabolites’.
Capecitabine Accordi toimeaine kapetsitabiin on antimetaboliitide (raku normaalset ainevahetust pärssiv aine) hulka kuuluv tsütotoksiline ravim (ravim, mis hävitab poolduvaid rakke, näiteks kasvajarakke).
The active substance in Capecitabine Medac, capecitabine, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells) that belongs to the group ‘anti-metabolites’.
Capecitabine Medaci toimeaine kapetsitabiin on antimetaboliitide (raku normaalset ainevahetust pärssivate ainete) hulka kuuluv tsütotoksiline aine (ravim, mis hävitab poolduvaid rakke, näiteks vähirakke).
The active substance in Capecitabine SUN, capecitabine, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells) that belongs to the group ‘anti-metabolites’.
Capecitabine SUNi toimeaine kapetsitabiin on antimetaboliitide (raku normaalset ainevahetust pärssivad ained) hulka kuuluv tsütotoksiline ravim (poolduvaid rakke, näiteks vähirakke hävitav ravim).
The active substance in Capecitabine Teva, capecitabine, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells) that belongs to the group ‘anti-metabolites’.
Capecitabine Teva toimeaine kapetsitabiin on antimetaboliitide (raku normaalset ainevahetust pärssivad ained) hulka kuuluv tsütotoksiline ravim (poolduvaid rakke, näiteks vähirakke hävitav ravim).
The active substance in Caspofungin Accord, caspofungin, belongs to a group of antifungal medicines known as ‘echinocandins’.
Caspofungin Accordis sisalduv toimeaine kaspofungiin kuulub seenevastaste ravimite ehhinokandiinide rühma.
The active substance in Cayston, aztreonam, is an antibiotic that belongs to the group ‘beta-lactams’.
Caystoni toimeaine astreonaam on beetalaktaamide gruppi kuuluv antibiootikum.
The active substance in Celsentri, maraviroc, is a ‘CCR5 antagonist’.
Celsentri toimeaine maravirok on CCR5-antagonist.
The active substance in Ceplene, histamine dihydrochloride, is an immune modulator.
Ceplene toimeaine histamiindihüdrokloriid on immunomodulaator.
The active substance in Cerdelga, eliglustat, works by blocking the action of an enzyme involved in the production of the glucosylceramide fat.
Cerdelga toimeaine eliglustaat blokeerib glükosüültseramiidi tekkimises osaleva ensüümi toime.
The active substance in Cetrotide, cetrorelix, blocks the effects of luteinising-hormone-releasing hormone (LHRH) in the body.
Cetrotide toimeaine tsetroreliks blokeerib organismi loodusliku hormooni – luteiniseerivat hormooni vabastava hormooni (LHRH) – toime.
The active substance in ChondroCelect is the patient’s own cartilage cells.
ChondroCelecti toimeaine on patsiendi enda kõhrerakud.
The active substance in Ciambra, pemetrexed, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells), which belongs to the group ‘antimetabolites’.
Ciambra toimeaine pemetrekseed on antimetaboliitide rühma kuuluv tsütotoksiline ravim (ravim, mis hävitab jagunevaid rakke, näiteks vähirakke).
The active substance in Cimalgex, cimicoxib, belongs to a class of medicines called non-steroidal anti- inflammatory drugs (NSAIDs).
Cimalgexi toimeaine tsimikoksiib kuulub mittesteroidsete põletikuvastaste ravimite (NSAID) klassi.
The active substance in Cimzia, certolizumab pegol, is an immunosuppressant medicine, a medicine that reduces the activity of the immune system (the body’s natural defences).
Cimzia toimeaine pegooltsertolisumaab on immunosupressant ehk aine, mis pärsib immuunsüsteemi (organismi loodusliku kaitsemehhanismi) talitlust.
The active substance in Cinacalcet Mylan, cinacalcet, works by increasing the sensitivity of the calcium- sensing receptors on the parathyroid glands that regulate PTH secretion.
Cinacalcet Mylani toimeaine tsinakaltseet suurendab kõrvalkilpnäärmete pinnal olevate ja PTH eritumist reguleerivate kaltsiumitundlike retseptorite tundlikkust.
The active substance in Cinryze, human C1 inhibitor, is a protein extracted from human blood.
Cinryze toimeaine on inimese C1 inhibiitor, mis on inimverest eraldatud valk.
The active substance in Coagadex is human factor X isolated from the plasma of blood donors.
Coagadexi toimeaine inimese X hüübimistegur on eraldatud doonoriplasmast.
The active substance in Colobreathe, colistimethate sodium, is an antibiotic from the polymyxin group.
Colobreathe’i toimeaine kolistimetaatnaatrium on polümüksiinide rühma kuuluv antibiootikum.
The active substance in Comfortis, spinosad, is an insecticide which works by interfering with certain receptors (nicotinic acetylcholine receptors) in the fleas’ nervous system, which results in their subsequent paralysis and death.
Comfortise toimeaine spinosaad on insektitsiid, mis seondub kirpude närvisüsteemi teatud retseptoritega (nikotiinatsetüülkoliini retseptoritega), mille tulemuseks on kirpude paralüüs ja surm.
The active substance in Corlentor, ivabradine, works by blocking the ‘If currents’ in the sinus node, the ‘pacemaker’ for the heart that controls the heart’s contractions and regulates the heart rate.
Corlentori toimeaine ivabradiin blokeerib siinussõlmes (südame kokkutõmbeid juhtiv ja löögisagedust reguleeriv südamepiirkond) tekkiva nn If-voolu.
The active substance in Cortavance, hydrocortisone aceponate, is a steroid which is a type of substance that helps to reduce inflammation.
Cortavance’i toimeaine hüdrokortisoonatseponaat on steroid, mis on põletikku vähendav aine.
The active substance in Cotellic, cobimetinib, is an inhibitor of MEK, a protein involved in stimulating normal cell division.
Cotellicu toimeaine kobimetiniib on rakkude normaalse jagunemise stimuleerimises osaleva MEK- proteiini inhibiitor.
The active substance in Cresemba, isavuconazole, belongs to the ‘triazole’ class of antifungal medicines.
Cresemba toimeaine isavukonasool kuulub seenevastaste ravimite triasoolide klassi.
The active substance in Cubicin powder for solution for injection or infusion is daptomycin.
Cubicin’i süste- või infusioonilahuse pulbri toimeaine on daptomütsiin.